Skip to content
i2E
  • Programs
    • E3
    • ACT Tulsa
    • Love’s Entrepreneur’s Cup
    • OKBio
  • Client Portfolio
  • Services
    • Access to Funding
    • Venture Advisory Services
  • About
    • Our Values
    • Meet Our Team
    • Board of Directors
    • Corporate Partners
  • Contact
  • Media
Menu
  • Programs
    • E3
    • ACT Tulsa
    • Love’s Entrepreneur’s Cup
    • OKBio
  • Client Portfolio
  • Services
    • Access to Funding
    • Venture Advisory Services
  • About
    • Our Values
    • Meet Our Team
    • Board of Directors
    • Corporate Partners
  • Contact
  • Media
Search

Q&A with Manu Nair

Get in Touch

OMRF’s Manu Nair discusses commercializing technologies.

Copyright © 2014, The Oklahoma Publishing Company

Q: You most recently worked for the prestigious Mayo Clinic. Why did you leave there to join the Oklahoma Medical Research Foundation?

manu nair omrfA: It may not be as well known in Oklahoma, but OMRF is prestigious too. In the world of biotherapeutics, OMRF is known around the world for the caliber of our researchers and the quality of work our scientists do. The foundation has a strong portfolio of discoveries that are ripe for commercialization. I’m looking forward to building a team and finding development partners so we can put OMRF breakthroughs to work benefiting patients.

Q: What did you learn at Mayo that can be replicated at OMRF?

A: I learned that technology ventures have to be run as a proactive business. At the Mayo Clinic, they look at technologies as they come in and make patenting decisions based on commercial potential. They have a “cradle-to-grave” model with the infrastructure to move discoveries from the lab to the market. Oklahoma has some of the pieces in place to do the same thing. We need to fill in the gaps so we can become a true competitor.

Q: How do you keep up with the science?

A: My background is law and business. I don’t have a science degree. What I do have is a passion for the field, so I read a lot. I pay attention to what other institutions are doing, and I subscribe to a number of publications to make sure I know where the field is moving. That puts me in a position to at least be conversant when I talk to our scientists, who are, of course, experts in their fields.

Q: How do you make money with obscure medical discoveries?

A: Not every discovery is going to make money, but obscurity doesn’t mean a discovery isn’t worth pursuing. Part of our role is evaluating technologies. We look at the purpose: Is it a therapeutic? Is it a diagnostic? Is it a research tool that will help other labs? Really, it comes down to knowing what we have — which requires me to be in close contact with our researchers — and knowing what drug companies, investors and other researchers are interested in developing. It’s a matchmaking role in many ways.

PAULA BURKES, BUSINESS WRITER

Click here to read the article at newsok.com

 

 

Author

  • admin admin

More News

Loading...
Black doctor smiling with stethoscope
Blog, i2E
02.09.23

Titan Intake Automates Patient Referrals to Accelerate Care

Read more
man and woman reviewing paperwork at a table
Blog, i2E, News
01.10.23

Stories of Oklahoma Innovation: Building a Startup

Read more
woman in lab conducting a study
Blog, i2E
12.13.22

Bayesic Technologies Improves Effectiveness and Efficiency of Data Analysis in Healthcare

Read more
Bison grazing fields
Blog
11.30.22

Bison Underground Merges Nature, Science, and Technology to Tackle Climate Change

Read more
African American family sitting on couch reading and chatting
Blog, E3, i2E
11.22.22

Fokes Connects Families, Caregivers and Care Agencies for Smoother Communications and Care 

Read more
i2e blog post graphic
Blog, News
11.03.22

Introducing: Stories of Oklahoma Innovation

Read more
Default Featured Image
OKBio
06.28.22

Oklahoma Grown! i2E Invests in BIO startups

Read more
Default Featured Image
OKBio
06.13.22

Oklahoma Medical Research Foundation BIO

Read more
Default Featured Image
OKBio
06.13.22

Moleculera Labs BIO

Read more
Default Featured Image
OKBio
06.13.22

University of Oklahoma Health Sciences Center BIO

Read more
Default Featured Image
OKBio
06.13.22

Oklahoma State University BIO

Read more
Default Featured Image
OKBio
06.13.22

ECHO Investment Capital BIO

Read more
i2E

Oklahoma City Office

840 Research Parkway, Suite 250
OKC, OK 73104
+1 (405) 235.2305

Tulsa Office

100 S. Cincinnati Ave – Suite 514
Tulsa, OK 74103
+1 (918) 582.5592

  • Client Portfolio
  • About Us
  • Media
  • Events
  • Contact
  • Resources

© 2022 i2E Privacy Policy

Follow us:

Facebook Twitter Linkedin

Programs

  • E3
  • ACT Tulsa
  • Love's Entrepreneur's Cup
  • OKBio
  • Client Portfolio

Services

  • Access to Funding
  • Venture Advisory Services
  • Contact
  • About
  • Our Values
  • Our Team
  • Board of Directors
  • Corporate Partners
  • Media
i2E